The corneal epithelium: clinical relevance of cytokine-mediated responses to maintenance of corneal health;O epitélio da córnea: Relevância clínica das respostas mediadas por citocinas para manter a saúde da córnea

Arquivos Brasileiros de Oftalmologia

Volumn 71, Issue 6 SUPP, 2009, Pages 80-88

  Reinach, P S ^a   Pokorny, K S ^b  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b INSTITUTE OF OPHTHALMOLOGY AND VISUAL SCIENCE   (United States)

Author keywords

Corneal epithelium; Cytokines; Dry eye syndromes; Intercellular signaling peptides and proteins; Wound healing

Indexed keywords

CYTOKINE; EPIDERMAL GROWTH FACTOR;

CELL PROLIFERATION; CLASSIFICATION; CORNEA EPITHELIUM; CYTOLOGY; HUMAN; PHYSIOLOGY; REVIEW; WOUND HEALING;

CELL PROLIFERATION; CYTOKINES; EPIDERMAL GROWTH FACTOR; EPITHELIUM, CORNEAL; HUMANS; WOUND HEALING;

EID: 68949217011     PISSN: 00042749     EISSN: 16782925     Source Type: Journal    
DOI: 10.1590/s0004-27492008000700016     Document Type: Article

References (107)

1. Hogan MJ, Alvarado JA, Weddell JE. The cornea. In: Hogan MJ, Alvarado JA, Weddell JE, editors. Histology of the human eye. Philadelphia: WB Saunders; 1971. p. 55-111.
2. Ruberti JW, Klyce SD. NaCl osmotic perturbation can modulate hydration control in rabbit cornea. Exp Eye Res. 2003;76(3):349-59.
3. Reuss L, Reinach PS, Weinman SA, Grady TP. Intracellular ion activities and Cl transport mechanisms in bullfrog corneal epithelium. Am J Physiol. 1983;244(5):336-47.
4. Klyce SD. Stromal lactate accumulation can account for corneal edema osmo- tically following epithelial hypoxia in the rabbit. J Physiol. 1981;321:49-64.
5. Klyce SD. Enhancing fluid secretion by the corneal epithelium. Invest Oph- thalmol Vis Sci. 1977;16(10):968-73.
6. Bonanno JA, Klyce SD, Cragoe EJ Jr. Mechanism of chloride uptake in rabbit corneal epithelium. Am J Physiol. 1989;257(2 Pt 1):C290-6.
7. Lu L, Reinach PS, Kao WWY. Corneal epithelial wound healing. Exp Biol Med. 2001;226(7):653-64.
8. Klenker B, Sheardown H, Jones L. Growth factors in the tear film: role in tissue maintenance, wound healing, and ocular pathology. Ocular Surface. 2007;5(3):228-39.
9. Wilson SE, Chaurasia SS, Medeiros FW. Apoptosis in the initiation, modu- lation, and termination of the corneal wound healing response. Exp Eye Res. 2007;85(3):305-11.
10. Kao WW. Ocular surface tissue morphogenesis in normal and disease states revealed by genetically modified mice. Cornea. 2006;25(10 Suppl 1):S7-19.
11. Netto MV, Mohan RR, Ambrosio R Jr, Hutcheon AE, Zeiske JD, Wilson SE. Wound healing in the cornea: A review of refractive surgery complica- tions and new prospects for therapy. Cornea. 2005;24(5):509-22.
12. Bazan HE. Cellular and molecular events in corneal wound healing: Signi- ficance of lipid signaling. Exp Eye Res. 2005;80(4):453-63.
13. Klenker B, Sheardown H. Growth factors in the anterior segment: role in maintenance of wound healing and ocular pathology. Exp Eye Res. 2004;79 (5):677-88.
14. Kuo IC. Corneal wound healing. Curr Opin Ophthalmol. 2004;15(4):311-5.
15. Mohan RR, Sharma A, Netto MV, Sinha S, Wilson SE. Gene therapy in the cornea. Prog Retina Eye Res. 2005;24(5):537-59.
16. Saika S. TGF-beta signal transduction in corneal wound healing as a therapeutic target. Cornea. 2004;23(8 Suppl):525-30.
17. Saika S., Yamanaka O, Sumioka T, Miyamoto T, Miyazaki K, Okada Y, et al. Fibrotic disorders in the eye: targets of gene therapy. Prog Retina Eye Res. 2008;27(2):177-96.
18. Mircheff AK. Sjögren's syndrome as failed local immunohomoeostasis: Prospects for cell-bound therapy. Ocular Surface. 2003;1(4):160-79.
19. Kaufman HE. Treatment of viral diseases of the cornea and external eye. Prog Retina Eye Res. 2000;19(1):69-85.
20. Kaufman SC. Anterior segment complications of herpes zoster ophthalmicus. Ophthalmology. 2008;115(2 Suppl):524-32.
21. Kaye S, Choudhary A. Herpes simplex keratitis. Prog Retina Eye Res. 2006; 25(4):355-80.
22. Vincent AL, Rootman D, Manier FL, Heon E. A molecular perspective on corneal dystrophies. Dev Ophthalmol. 2003;37:50-66.
23. Wall V, Yen MT, Yang MC, Huang AJ, Pflugfelder SC. Management of the late ocular sequelae of Steven-Johnson syndrome. Ocular Surface. 2003; 1(4):192-201.
24. Malta JB, Soong HK. Diamond burr superficial keratectomy in the treatment of visually significant anterior segment corneal lesions. Arq Bras Oftalmol. 2008;71(3):415-8.
25. Klausner EA, Peer D, Chapman RL, Multack RF, Andurkar SV. Corneal gene therapy. J Control Release. 2007;124(3):107-33.
26. Kakazu A, Sharma G, Bazan HE. Association of protein tyrosine phospha- tases (PTPs)-1B with c-Met receptor and modulation of corneal epithelial wound healing. Invest Ophthalmol Vis Sci. 2008;48(7):2927-35.
27. Sharma GD, He J, Bazan HE. p38 and Erk1/2 coordinate cellular migration and proliferation in epithelial wound healing: evidence of crosstalk activation between MAP kinase Cascades. J Biol Chem. 2003;278(24):21989-97.
28. Wang, Z, Yang H, Tachado SD, Bildin VN, Koziel H, Reinach PS. Phospha- tase-mediated crosstalk control of ERK and p38 MAPK signaling in corneal epithelial cells. Invest Ophthalmol Vis Sci. 2006;47(12):5267-75.
29. Wilson SE, Chen L, Mohan RR, Liang Q, Lin J. Expression of HGF, KGF, EGF, and receptor messenger in corneal epithelial cells after wounding. Exp Eye Res. 1999;68(4):377-97.
30. Foerster CG, Cursiefen C, Kruse FE. Persisting corneal erosion under cetuxi- mab (Erbitux) treatment (epidermal growth factor receptor antibody). Cornea. 2008;27(5):612-4.
31. Lozano JS, Chay EY, Heeley J, Sullenberger R, Klarlund JK. Activation of epidermal growth factor receptor by hydrogels in artificial tears. Exp Eye Res. 2008;86(3):500-5.
32. Sheardown H, Cheng YL. Mechanisms of corneal epithelial wound healing. Chem Eng Sci. 1996;52:4517-29.
33. Tao W, Liou GI, Wu X, Abney TO, Reinach PS. ETB and epidermal growth factor stimulation of wound closure in bovine corneal epithelial cells. Invest Ophthalmol Vis Sci. 1995;36(13):2614-22.
34. Ohashi Y, Motokura M, Kinoshita Y, Mano T, Watanabe H, Kinoshita S, et al. Presence of epidermal growth factor in human tears. Invest Ophthalmol Vis Sci. 1989;30(8):1879-82.
35. Wilson SE, Lloyd SA Kennedy RH. Epidermal growth factor messenger RNA production in human lacrimal gland. Cornea. 1991;10(6):519-24.
36. Jester JV, Petroll WM, Cavanagh HD. Corneal stromal wound healing in refractive surgery: the role of myofibroblasts. Prog Retin Eye Res. 1999; 18(3):311-56.
37. Cordeiro MF, Mead A, Ali RR, Alexander RA, Murray S, Chen C, et al. Novel antisense oligonucleotides targeting TGF-beta inhibits in vivo scarring and improves surgical outcomes. Gene Ther. 2003;10(1):59-71.
38. Nakamura H, Siddigui SS, Shen X, Malik AB, Pulido JS, Kumar NM, Yue BY. RNA interference targeting transforming growth factor type II receptor suppresses ocular inflammation and fibrosis. Mol Vis. 2004;10:703-11.
39. Chen Z, Tong L, Li Z, Yoon KC, Oi H, Farley W, et al. Hyperosmolarity- induced cornification of human corneal epithelial cells is regulated by JNK MAPK. Invest Ophthalmol Vis Sci. 2008;49(2):539-49.
40. Chang EJ, Im YS, Kay EP, Kim JY, Lee JE, Lee HK. The role of nerve growth factor in hyperosmolar stress induced apoptosis. J Cell Physiol. 2008;216(1):69-77.
41. Saika S, Ikeda K, Yamanaka O, Flanders KC, Okada Y, Miyamoto T, et al. Loss of tumor necrosis factor alpha potentiates transforming growth factor beta- mediated pathogenic tissue response during wound healing. Am J Pathol. 2006;168(6):184-60.
42. Wang L, Reinach P, Lu L. TNF-alpha promotes cell survival through sti- mulation of K+ channel and NF kappa B activity in corneal epithelial cells. Exp Cell Res. 2005;311(1):39-48.
43. Klyce SD, Wong RK. Site and mode of adrenaline action on chloride transport across the rabbit corneal epithelium. J Physiol. 1977;266(3):777-99.
44. Klyce SD. Enhancing fluid secretion by the corneal epithelium. Invest Oph- thalmol Vis Sci. 1977;16(10):968-73.
45. Neufeld AH, Ledgard SE, Jumblatt MM, Klyce SD. Serotonin-stimulated cyclic Invest Ophthalmol Vis Sci. 1982;23(2):193-8.
46. Klyce SD, Palkama KA, Härkönen M, Marshall WS, Huhtaniitty S, Mann KP, et al. Neural serotonin stimulates chloride transport in the rabbit corneal epithelium. Invest Ophthalmol Vis Sci. 1982;23(2):181-92.
47. Socci RR, Tachado SD, Aronstam RS, Reinach PS. Characterization of the muscarinic receptor subtypes in the bovine corneal epithelial cells. J Ocul Pharmacol Ther. 1996;12(3):259-69.
48. Pesin SR, Candia OA. Acetylcholine concentration and its role in ionic trans- port by the corneal epithelium. Invest Ophthalmol Vis Sci. 1982;22(5):651-9.
49. Cavanagh HD, Colley AM. Cholinergic, adrenergic, and PGE1 effects on cyclic nucleotides and growth in cultured corneal epithelium. Metab Pediatr Syst Ophthalmol. 1982;6(2):63-74.
50. Yang H, Reinach PS, Koniarek JP, Wang Z, Iserovich P, Fischbarg J. Fluid transport by cultured corneal epithelial cell layers. Br J Ophthalmol. 2000;84 (2):199-204.
51. Takagi H, Reinach PS, Yoshimura N, Honda Y. Endothelin-1 promotes corneal epithelial wound healing in rabbits. Curr Eye Res. 1994;13(8):625-8.
52. Fujihara T, Murakami T, Fujita H, Nakamura M, Nakata K. Improvement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model. Invest Ophthalmol Vis Sci. 2001;42(1):96-100.
53. Capó-Aponte JE, Wang Z, Bildin VN, Pokorny KS, Reinach PS. Fate of hypertonicity-stressed corneal epithelial cells depends on differential MAPK activation and p38MAPK/Na-K-2Cl cotransporter1 interaction. Exp Eye Res. 2007;84(2):361-72.
54. Yang H, Wang Z, Miyamoto Y, Reinach PS. Cell signaling pathways mediating epidermal growth factor stimulation of Na:K:2Cl co transport activity in rabbit corneal epithelial cells. J Membr Biol. 2001;183(2):93-101.
55. Kang SS, Li T, Xu D, Reinach PS, Lu L. Inhibitory effect of PGE2 on EGF- induced MAP kinase activity and rabbit corneal epithelial proliferation. Invest Ophthalmol Vis Sci. 2000;41(8):2164-9.
56. Imanishi J, Kamiyama K, Iguchi I, Kita M, Sotozono C, Kinoshita S. Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res. 2000;19(1):113-29.
57. Jorissen RN, Walker F, Pouliot N, Garrett TP, Ward CW, Burgess AW. Epidermal growth factor receptor: mechanisms of activation and signaling Exp Cell Res. 2003;284(1):31-53.
58. Zhang Y, Liou GI, Gulati AK, Akhtar RA. Expression of phosphatidylinositol 3-kinase during EGF-stimulated wound repair in rabbit corneal epithelium Invest Ophthalmol Vis Sci. 1999;40(12):2819-26.
59. Yang H, Sun X, Wang Z, Ning G, Zhang F, Kong J, et al. EGF stimulated growth by enhancing capacitative calcium entry in corneal epithelial cells. J Membr Biol. 2003;194(1):47-58.
60. Smyth JT, Dehaven WI, Jones BF, Mercer JC, Trebak M, Vazquez G, et al. Emerging perspectives in store-operated Ca2+ entry: roles of Orai, Stim and TRP. Biochim Biophys Acta. 2006;1763(11):1147-60.
61. Yang H, Mergler S, Sun X, Wang Z, Lu L, Bonanno JA, et al. TPC4 knockdown suppresses epidermal growth factor-induced store-operated channel activation and growth in human corneal epithelial cells. J Biol Chem. 2005;16;280(37):32230-7.
62. Dinbergs ID, Brown L, Edelman ER Cellular response to transforming growth factor-beta1 and basic fibroblast growth factor depends on release kinetics and extracellular matrix interactions. J Biol Chem. 1996;22;271(47):29822-9.
63. Honma Y, Nishida K, Sotozono C, Kinoshita S. Effect of transforming growth factor-beta1 and -beta2 on in vitro rabbit corneal epithelial cell proliferation promoted by epidermal growth factor, keratinocyte growth factor, or hepatocyte growth factor. Exp Eye Res. 1997;65(3):391-6.
64. Roberts AB. The ever-increasing complexity of TGF-beta signaling. Cytokine Growth Factor Rev. 2002;13(1):3-5.
65. Funderburgh JL, Funderburgh ML, Mann MM, Corpuz L, Roth MR. Proteo- glycan expression during transforming growth factor beta-induced keratocyte-myofibroblast transdifferentiation. J Biol Chem. 2001;276(47): 44173-8
66. Brown CT, Nugent MA, Lau FW, Trinkaus-Randall V. Characterization of proteoglycans synthesized by cultured corneal fibroblasts in response to transforming growth factor beta and fetal calf serum. J Biol. Chem. 1999; 274(11):7111-9.
67. Hongo M, Itoi M, Yamaguchi N, Imanishi J. Distribution of epidermal growth factor (EGF) receptors in rabbit corneal epithelial cells, keratocytes and endothelial cells, and the changes induced by transforming growth factor- beta 1. Exp Eye Res.1992;54(1):9-16.
68. Poulaki, V, Colby, K Genetics of anterior and stromal corneal dystrophies. Seminars in Ophthalomology. 2008;23(1):9-17.
69. Rubin JS, Osada H, Finch PW, Taylor WG, Rudikoff S, Aaronson SA. Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci USA. 1989;86(3):802-6.
70. Sotozono C, Kinoshita S, Kita M, Imanishi J. Paracrine role of keratinocyte growth factor in rabbit corneal epithelial cell growth. Exp Eye Res. 1994;59(4): 385-91.
71. Grierson I, Heathcote L, Hiscott P, Hogg P, Briggs M, Hagan S. Hepatocyte growth factor/scatter factor in the eye. Prog Retin Eye Res. 2000:19(6):779-802.
72. McBain VA, Forrester JV, McCaig CD. HGF, MAPK, and a small physiological electric field interact during corneal epithelial cell migration. Invest Ophthalmol Vis Sci. 2003;44(2):540-7.
73. Wilson SE, Liu JJ, Mohan RR. Stromal-epithelial interactions in the cornea. Prog Retin Eye Res. 1999;18(3):293-309.
74. Tervo T, Vesaluoma M, Bennett GL, Schwall R, Helena M, Liang Q, et al. Tear hepatocyte growth factor (HGF) availability increases markedly after excimer laser surface ablation. Exp Eye Res. 1997;64(4):501-4.
75. Jones SM, Kazlauskas A. Connecting signaling and cell cycle progression in growth factor-stimulated cells. Oncogene. 2000;19(49):5558-67.
76. Wilson SE, Mohan RR, Mohan RR, Ambrósio R Jr, Hong J, Lee J. The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Prog Retin Eye Res. 2001:20(5);625-37.
77. Boilly B, Vercoutter-Edouart AS, Hondermarck H, Nurcombe V, Le Bourhis X. FGF signals for cell proliferation and migration through different pathways. Cytokine Growth Factor Rev. 2000:11(4):295-302.
78. Song QH, Klepeis VE, Nugent MA, Trinkaus-Randall V TGF-beta1 regulates TGF-beta1 and FGF-2 mRNA expression during fibroblast wound healing. Mol Pathol. 2002;55(3):164-76.
79. Dinbergs ID, Brown L, Edelman ER Cellular response to transforming growth factor-beta1 and basic fibroblast growth factor depends on release kinetics and extracellular matrix interactions. J. Biol Chem. 1996;271(47):29822-9.
80. Saghizadeh M, Chwa M, Aoki A, Lin B, Pirouzmanesh A, Brown DJ, et al. Altered expression of growth factors and cytokines in keratoconus, bullous keratopathy and diabetic human corneas. Exp Eye Res. 2001;73(2):179-89.
81. You L, Kruse FE, Völcker HE. Neurotrophic factors in the human cornea. Invest Ophthalmol Vis Sci. 2000;41(3):692-702.
82. Lambiase A, Rama P, Bonini S, Caprioglio G, Aloe L. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med. 1998;338(17): 1174-80.
83. Lambiase A, Bonini S, Micera A, Rama P, Bonini S, Aloe L. Expression of nerve growth factor receptors on the ocular surface in healthy subjects and during manifestation of inflammatory diseases. Invest Ophthalmol Vis Sci. 1998:34(7):1272-5.
84. Kruse FE, Tseng SC. Growth factors modulate clonal growth and differen- tiation of cultured rabbit limbal and corneal epithelium. Invest Ophthalmol Vis Sci. 1993;34(6):1963-76.
85. Chang EJ, Im YS, Kay EP, Kim JY, Lee JE, Lee HK. The role of nerve growth factor in hyperosmolar stress induced apoptosis. J Cell Physiol. 2008; 216(1):69-77.
86. Smith RE, Sadun AA. Clearing the cornea with nerve growth factor. N Engl J Med. 199823;338(17):1222-3.
87. Comment in: N Eng J Med. 1998;338(17):1174-8.
88. van Setten GB. Vascular endothelial growth factor (VEGF) in normal human corneal epithelium: detection and physiological importance. Acta Ophthalmol Scand. 1997;75(6):649-52.
89. Nakamura Y, Sotozono, C, Kinoshita, S. The epidermal growth factor recep- tor (EGFR): role in corneal wound healing and homeostasis. Exp Eye Res. 2000; 72(5):511-17.
90. Kokawa N, Sotozono C, Nishida K, Kinoshita S. High total TGF-beta 2 levels in normal human tears. Curr Eye Res.1996;15(3):341-3.
91. Honma Y, Nishida K, Sotozono C, Kinoshita S. Effect of transforming growth factor-beta1 and -beta2 on in vitro rabbit corneal epithelial cell prolife- ration promoted by epidermal growth factor, keratinocyte growth factor, or hepatocyte growth factor. Exp Eye Res. 1997;65(3):391-6.
92. Ohji M, Mandarino L, SundarRaj N, Thoft RA. Corneal epithelial cell attach- ment with endogenous laminin and fibronectin. Invest Ophthalmol Vis Sci. 1993;34(8):2487-92.
93. Lim M, Goldstein MH, Tuli S, Schultz GS. Growth factor, cytokine and protease interactions during corneal wound healing. Ocul Surf. 2003;1(2):53-65.
94. Kitazawa T, Kinoshita S, Fujita K, Araki K, Watanabe H, Ohashi Y, et al. The mechanism of accelerated corneal epithelial healing by human epidermal growth factor. Invest Ophthalmol Vis Sci. 1990;31(9):1773-8.
95. Suzuki K, Saito J, Yanai R, Yamada N, Chikama T, Seki K, et al. Cell- matrix and cell-cell interactions during corneal epithelial wound healing. Prog Retin Eye Res. 2003;22(2):113-33.
96. Li DQ, Tseng SC. Differential regulation of keratinocyte growth factor and 1hepatocyte growth factor/scatter factor by different cytokines in human corneal 1 and limbal fibroblasts. J Cell Physiol. 1997;172(3):361-72.
97. Fini ME. Keratocyte and fibroblast phenotypes in the repairing cornea. Prog Retin Eye Res. 1999;18(4):529-51.
98. Yanai R, Yamada N, Kugimiya N, Inui M, Nishida T. Mitogenic and antiapoptotic effects of various growth factors on human corneal fibroblasts. Invest Ophthalmol Vis Sci. 2002;43(7):2122-6.
99. Maltseva O, Folger P, Zekaria D, Petridou S, Masur SK. Fibroblast growth factor reversal of the corneal myofibroblast phenotype. Invest Ophthalmol Vis Sci. 2001;42(11):2490-5.
100. Ueno H, Sakamoto T, Nakamura T, Oi Z, Astuchi N, Takeshita A, et al. A soluble transforming growth factor beta receptor expressed in muscle prevents liver fibrogenesis and dysfunction in rats. Hum Gene Ther. 2000;11(1):33-42.
101. Saika S, Yamanaka O, Sumioka T, Miyamoto T, Miyazaki K, Okada Y, et al. Fibrotic disorders in the eye: targets of gene therapy. Prog Retin Eye Res. 2008;27(2):177-96.
102. Saika S, Yamanaka O, Flanders KC, Okada Y, Miyamoto T, Sumioka T, et al. Epithelial-mesenchymal transition as a therapeutic target for prevention of ocular tissue fibrosis. Endocr Metab Immune Disord Drug Targets. 2008;8(1):69-76.
103. Joussen AM, Poulaki V, Mitsiades N, Stechschulte SU, Kirchhof B, Dartt DA, et al. VEGF-dependent conjunctivalization of the corneal surface. Invest Ophthalmol Vis Sci. 2003;44(1):117-23.
104. Welge-Lüssen U, May CA, Neubauer AS, Priglinger S. Role of tissue growth factors in aqueous humor homeostasis [Review]. Curr Opin Ophthal- mol. 2001;12(2):94-9.
105. Tripathi RC, Li J, Chan WF, Tripathi BJ. Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. Exp Eye Res. 1994;59(6):723-7.
106. Saika S, Ikeda K, Yamanaka O, Miyamoto T, Ohnishi Y, Sato M, et al. Expression of Smad7 in mouse eyes accelerates healing of corneal tissue after exposure to alkali. Am J Pathol. 2005;166(5):1405-18.
107. Campochiaro PA. Potential applications for RNAi to probe pathogenesis and develop new treatments for ocular disorders. Gene Ther. 2006;13(6):559-62.